289 related articles for article (PubMed ID: 34957025)
21. When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season.
Galli C; Pellegrinelli L; Bubba L; Primache V; Anselmi G; Delbue S; Signorini L; Binda S; Cereda D; Gramegna M; Pariani E; The Ili Sentinel Physicians Group
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923819
[TBL] [Abstract][Full Text] [Related]
22. The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps.
Wong A; Barrero Guevara LA; Goult E; Briga M; Kramer SC; Kovacevic A; Opatowski L; Domenech de Cellès M
PLoS Pathog; 2023 Mar; 19(3):e1011167. PubMed ID: 36888684
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain].
Alonso Bilbao JL; de Arriba Fernández A; Espiñeira Francés A; Cabeza Mora A; Gutiérrez Pérez A; Díaz Barreiros MA
Rev Esp Quimioter; 2023 Apr; 36(2):180-186. PubMed ID: 36709415
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China.
Ma S; Lai X; Chen Z; Tu S; Qin K
Int J Infect Dis; 2020 Jul; 96():683-687. PubMed ID: 32470606
[TBL] [Abstract][Full Text] [Related]
25. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis.
Krumbein H; Kümmel LS; Fragkou PC; Thölken C; Hünerbein BL; Reiter R; Papathanasiou KA; Renz H; Skevaki C
Rev Med Virol; 2023 Jan; 33(1):e2365. PubMed ID: 35686619
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective.
Ghaznavi H; Shirvaliloo M; Sargazi S; Mohammadghasemipour Z; Shams Z; Hesari Z; Shahraki O; Nazarlou Z; Sheervalilou R; Shirvalilou S
Cell Biol Int; 2022 Jul; 46(7):1009-1020. PubMed ID: 35322909
[TBL] [Abstract][Full Text] [Related]
27. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
[TBL] [Abstract][Full Text] [Related]
28. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Lin Z; Chen J; Han S
Expert Rev Anticancer Ther; 2021 Sep; 21(9):1055-1066. PubMed ID: 33970745
[No Abstract] [Full Text] [Related]
29. Coinfection of SARS-CoV-2 and Other Respiratory Pathogens.
Ma L; Wang W; Le Grange JM; Wang X; Du S; Li C; Wei J; Zhang JN
Infect Drug Resist; 2020; 13():3045-3053. PubMed ID: 32922049
[TBL] [Abstract][Full Text] [Related]
30. Coinfection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Influenza: An Evolving Puzzle.
Covin S; Rutherford GW
Clin Infect Dis; 2021 Jun; 72(12):e993-e994. PubMed ID: 33277660
[No Abstract] [Full Text] [Related]
31. A systematic review of the clinical characteristics of influenza-COVID-19 co-infection.
Varshney K; Pillay P; Mustafa AD; Shen D; Adalbert JR; Mahmood MQ
Clin Exp Med; 2023 Nov; 23(7):3265-3275. PubMed ID: 37326928
[TBL] [Abstract][Full Text] [Related]
32. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
Sarkar S; Khanna P; Singh AK
J Med Virol; 2021 Apr; 93(4):2385-2395. PubMed ID: 33331656
[TBL] [Abstract][Full Text] [Related]
33. A Case of Nosocomial Coinfection of SARS-CoV-2 and Influenza A Virus in a Hospitalized Patient with Acute Myocardial Infarction.
Shan N; Zheng Z
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213216
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
35. Immune responses in COVID-19 and tuberculosis coinfection: A scoping review.
Flores-Lovon K; Ortiz-Saavedra B; Cueva-Chicaña LA; Aperrigue-Lira S; Montes-Madariaga ES; Soriano-Moreno DR; Bell B; Macedo R
Front Immunol; 2022; 13():992743. PubMed ID: 36090983
[TBL] [Abstract][Full Text] [Related]
36. Viral Coinfection is Associated with Improved Outcomes in Emergency Department Patients with SARS-CoV-2.
Goldberg EM; Hasegawa K; Lawrence A; Kline JA; Camargo CA
West J Emerg Med; 2021 Oct; 22(6):1262-1269. PubMed ID: 34787549
[TBL] [Abstract][Full Text] [Related]
37. Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis.
Zhao X; Gang X; He G; Li Z; Lv Y; Han Q; Wang G
Front Endocrinol (Lausanne); 2020; 11():595109. PubMed ID: 33408692
[TBL] [Abstract][Full Text] [Related]
38. Association between Influenza and COVID-19 Viruses and the Risk of Atherosclerosis: Meta-Analysis Study and Systematic Review.
Jalili M; Sayehmiri K; Ansari N; Pourhossein B; Fazeli M; Azizi Jalilian F
Adv Respir Med; 2022 Aug; 90(4):338-348. PubMed ID: 36004963
[TBL] [Abstract][Full Text] [Related]
39. A Case Series of Patients Coinfected With Influenza and COVID-19.
Konala VM; Adapa S; Naramala S; Chenna A; Lamichhane S; Garlapati PR; Balla M; Gayam V
J Investig Med High Impact Case Rep; 2020; 8():2324709620934674. PubMed ID: 32522037
[TBL] [Abstract][Full Text] [Related]
40. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.
Khodamoradi Z; Moghadami M; Lotfi M
Arch Iran Med; 2020 Apr; 23(4):239-243. PubMed ID: 32271596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
